vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and INTERFACE INC (TILE). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $349.4M, roughly 1.1× INTERFACE INC). INTERFACE INC runs the higher net margin — 7.0% vs -19.6%, a 26.6% gap on every dollar of revenue. On growth, INTERFACE INC posted the faster year-over-year revenue change (4.3% vs 3.8%). Over the past eight quarters, INTERFACE INC's revenue compounded faster (9.8% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
PIII vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $349.4M |
| Net Profit | $-75.5M | $24.4M |
| Gross Margin | — | 38.6% |
| Operating Margin | -40.0% | 10.1% |
| Net Margin | -19.6% | 7.0% |
| Revenue YoY | 3.8% | 4.3% |
| Net Profit YoY | -28.8% | 12.1% |
| EPS (diluted) | $-23.08 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $349.4M | ||
| Q3 25 | $345.3M | $364.5M | ||
| Q2 25 | $355.8M | $375.5M | ||
| Q1 25 | $373.2M | $297.4M | ||
| Q4 24 | $370.7M | $335.0M | ||
| Q3 24 | $362.1M | $344.3M | ||
| Q2 24 | $379.2M | $346.6M | ||
| Q1 24 | $388.5M | $289.7M |
| Q4 25 | $-75.5M | $24.4M | ||
| Q3 25 | $-31.6M | $46.1M | ||
| Q2 25 | $-20.4M | $32.6M | ||
| Q1 25 | $-20.5M | $13.0M | ||
| Q4 24 | $-58.6M | $21.8M | ||
| Q3 24 | $-46.5M | $28.4M | ||
| Q2 24 | $-12.0M | $22.6M | ||
| Q1 24 | $-18.7M | $14.2M |
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 38.1% |
| Q4 25 | -40.0% | 10.1% | ||
| Q3 25 | -12.8% | 14.6% | ||
| Q2 25 | -9.6% | 13.9% | ||
| Q1 25 | -10.2% | 7.8% | ||
| Q4 24 | -37.4% | 8.8% | ||
| Q3 24 | -29.5% | 12.3% | ||
| Q2 24 | -8.3% | 11.0% | ||
| Q1 24 | -11.3% | 8.4% |
| Q4 25 | -19.6% | 7.0% | ||
| Q3 25 | -9.1% | 12.7% | ||
| Q2 25 | -5.7% | 8.7% | ||
| Q1 25 | -5.5% | 4.4% | ||
| Q4 24 | -15.8% | 6.5% | ||
| Q3 24 | -12.8% | 8.3% | ||
| Q2 24 | -3.2% | 6.5% | ||
| Q1 24 | -4.8% | 4.9% |
| Q4 25 | $-23.08 | $0.41 | ||
| Q3 25 | $-9.67 | $0.78 | ||
| Q2 25 | $-6.23 | $0.55 | ||
| Q1 25 | $-6.28 | $0.22 | ||
| Q4 24 | $-23.13 | $0.38 | ||
| Q3 24 | $-15.70 | $0.48 | ||
| Q2 24 | $-7.37 | $0.38 | ||
| Q1 24 | $-7.86 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $71.3M |
| Total DebtLower is stronger | $228.4M | $181.6M |
| Stockholders' EquityBook value | $-155.2M | $640.7M |
| Total Assets | $656.6M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $71.3M | ||
| Q3 25 | $37.7M | $187.4M | ||
| Q2 25 | $38.6M | $121.7M | ||
| Q1 25 | $40.1M | $97.8M | ||
| Q4 24 | $38.8M | $99.2M | ||
| Q3 24 | $63.0M | $115.6M | ||
| Q2 24 | $73.1M | $94.2M | ||
| Q1 24 | $27.3M | $89.8M |
| Q4 25 | $228.4M | $181.6M | ||
| Q3 25 | $252.8M | $307.8M | ||
| Q2 25 | $182.0M | $304.4M | ||
| Q1 25 | $171.1M | $302.9M | ||
| Q4 24 | $108.9M | $302.8M | ||
| Q3 24 | $133.2M | $337.9M | ||
| Q2 24 | $133.1M | $387.6M | ||
| Q1 24 | $118.1M | $391.8M |
| Q4 25 | $-155.2M | $640.7M | ||
| Q3 25 | $-18.7M | $621.0M | ||
| Q2 25 | $44.5M | $575.0M | ||
| Q1 25 | $63.3M | $513.1M | ||
| Q4 24 | $75.9M | $489.1M | ||
| Q3 24 | $120.5M | $501.6M | ||
| Q2 24 | $166.8M | $451.2M | ||
| Q1 24 | $146.6M | $428.5M |
| Q4 25 | $656.6M | $1.2B | ||
| Q3 25 | $683.6M | $1.3B | ||
| Q2 25 | $731.6M | $1.3B | ||
| Q1 25 | $783.9M | $1.2B | ||
| Q4 24 | $783.4M | $1.2B | ||
| Q3 24 | $833.3M | $1.2B | ||
| Q2 24 | $892.8M | $1.2B | ||
| Q1 24 | $855.9M | $1.2B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | 4.09× | 0.53× | ||
| Q1 25 | 2.71× | 0.59× | ||
| Q4 24 | 1.43× | 0.62× | ||
| Q3 24 | 1.11× | 0.67× | ||
| Q2 24 | 0.80× | 0.86× | ||
| Q1 24 | 0.81× | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $49.3M |
| Free Cash FlowOCF − Capex | — | $28.6M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | — | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $49.3M | ||
| Q3 25 | $-15.4M | $76.7M | ||
| Q2 25 | $-16.6M | $30.1M | ||
| Q1 25 | $-33.5M | $11.7M | ||
| Q4 24 | $-57.2M | $38.0M | ||
| Q3 24 | $-22.6M | $76.2M | ||
| Q2 24 | $-10.2M | $21.5M | ||
| Q1 24 | $-20.0M | $12.6M |
| Q4 25 | — | $28.6M | ||
| Q3 25 | — | $66.1M | ||
| Q2 25 | — | $22.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $24.4M | ||
| Q3 24 | — | $69.7M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | 0.0% | 4.1% | ||
| Q3 24 | 0.0% | 1.9% | ||
| Q2 24 | 0.0% | 2.8% | ||
| Q1 24 | 0.0% | 1.4% |
| Q4 25 | — | 2.02× | ||
| Q3 25 | — | 1.66× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | — | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
